DOI:
10.1039/B915479E
(Paper)
Metallomics, 2010,
2, 133-139
A proteome investigation of roxarsone degradation by Alkaliphilus oremlandii strain OhILAs
Received
29th July 2009
, Accepted 15th December 2009
First published on 24th December 2009
Abstract
Clostridial species predominate in both chicken gastrointestinal tract as well as litter where the organoarsenical roxarsone (3-nitro 4-hydroxybenzenearsonic acid) is anaerobically transformed releasing the more recognized toxic inorganic arsenic. 2D-gel electrophoresis and mass spectrometry were used to evaluate the changes in protein expression of Alkaliphilus oremlandii in response to different growth conditions (e.g., terminal electron acceptors) in order to explore the mechanism of microbial biotransformation of roxarsone. Aldehyde ferredoxin oxidoreductase, the enzyme that belongs to the xanthine oxidase family of molybdoenzymes was significantly overexpressed in the presence of roxarsone suggesting a role in the anaerobicmetabolism of this substituted nitrophenol.
Introduction
Roxarsone, 3-nitro 4-hydroxybenzenearsonic acid (structure 1), has seen widespread use as a feed additive in concentrated agricultural farming operations (CAFOs), particularly the poultry industry. It is used to control coccidiosis, a disease caused by a protozoal parasite, with the added benefit of enhanced growth. The majority of this organoarsenical is excreted in the manure, and is not retained in the chicken tissue. Since 1955 the annual production of broilers in the USA has increased from one billion to over 9 billion in 2008.1 In many cases, roxarsone was fed to these animals and the litter may contain from 15 to 48 mg kg−1 of arsenic.2–5 While organoarsenicals are thought to be innocuous, recent evidence indicates that some of the organoarsenicals may be more proangiogenic than the more common inorganic arsenicals.6 For example, three dimensional cell based assays have shown that roxarsone may have more angiogenic potential than arsenite.7
Organoarsenicals are thought to be stable and not degrade in the environment; however, it is now known that roxarsone can be degraded to inorganic arsenic due to microbial activity8,9 potentially posing an environmental concern.10 We have demonstrated11,12 that roxarsone can be converted to inorganic arsenic by anaerobic bacteria when grown with lactate as an electron donor. The measurable end products were acetate, 3-amino-4-hydroxy-benzenearsonic acid (3A4HBAA), and arsenate, all of which have been quantitated for mass balance. The products are the same whether the roxarsone is degraded by microbes present in the chicken litter or in a pure culture of Alkaliphilus oremlandii. The overall process that consumes lactate producing acetate is shown in eqn (1).
Interestingly, both 3A4BAA and
arsenate are produced simultaneously suggesting parallel pathways may be operative. Genome analysis of
A. oremlandii indicates the presence of many potential candidates, however, which proteins are involved in the biotransformation of
roxarsone remains unclear. Even at a more fundamental level whether specific proteins are expressed by
A. oremlandii under different growth conditions is not known. Herein we report proteomic results in an effort to identify proteins that are differentially expressed in cells grown on
roxarsone as compared to those grown on
lactate alone. The latter cultures (
i.e., cells grown on
lactate alone) provided a means to identify constitutively as well as differentially expressed proteins. Our results indicate that one protein in particular, aldehyde ferredoxin oxidoreductase, a molybdopterin-containing protein, is expressed more in the roxarsone grown cells.
Materials and methods
Cell growth. A. oremlandii strain OhILAs is a low G + C gram positive bacterium isolated from anoxic sediments from the Ohio River (Pittsburgh, PA, USA) that is capable of dissimilatory arsenate reduction and roxarsone transformation.12 Concentrations of 2.5 and 5 mM roxarsone inhibited growth of the organism, while the growth yields were enhanced with 0.5 and 1 mM roxarsone with maximal grown observed with 1 mM roxarsone.11,12 For the current set of experiments, cells were grown anaerobically in minimal media with either 1 mM roxarsone with 10 mM lactate or 10 mM lactate alone as described.11 The cells were harvested after 72 h of growth, and lysed by French pressure cell.
Protein
sample preparation and 2-D electrophoresis (2-DE)
The cell lysates were precipitated with trichloroacetic acid (TCA) at a final concentration of 10% on ice for 60 min. The protein pellet obtained by subsequent centrifugation was washed with acetone in order to remove residual TCA. Immobiline DryStrips (18 cm, pH 3-11 NL, GE Healthcare) were rehydrated in 350 μL rehydration solution containing 250 μg solubilized proteins for IEF. The rehydration solution consisted of 7 M urea, 2 M thiourea, 4% (w/v) CHAPS, 40 mM DTT and 2% (v/v) IPGbuffer and also contained a trace of bromophenol blue as tracking dye. Rehydration was allowed to proceed overnight to ensure maximal diffusion (attachment) of the proteins to the strips. Isoelectric focusing was carried out on an Ettan IPGphor3 unit (GE Healthcare) at 300 V for 2 h, 500 V for 1 h and 8 kV, to achieve a total of 70 kVh at 20 °C. Following IEF, the Drystrip cover fluid was poured off and the strips were equilibrated twice for 15 min each time with gentle shaking, first in 30% (v/v) glycerol, 6 M urea, 2% (w/v) SDS, 50 mM Tris-Cl, pH 8.8, 1% (w/v) DTT and a trace of bromophenol blue as tracking dye and the second time in this same solution, except that DTT was replaced by 2.5% (w/v) iodoacetamide. After this equilibration, each IEF strip was drained on a filter paper and immersed in SDS running buffer (25 mM Tris base, 0.192 M glycine and 0.1% SDS) before being sealed at the top of the PAGEgel with 1% agarose in SDS running buffer. The second-dimensional electrophoresis was run on 12.5% SDS-PAGE using an Ettan Daltsix electrophoresis unit (GE Healthcare) at 4 °C, 15 mA for 60 min followed by 30 mA for the remaining run. Electrophoresis was performed until the tracking dye reached the anodic end of the gels.13 Three replicate gels were run. For proteomic analysis, protein spots were visualized employing Coomassie Brilliant Blue G-250, according to Neuhoff et al.14 The stained gels were scanned by using a GS-800 densitometer (Bio-Rad). Image analysis was carried out by using the NIH Image J software. The most intense spots were analyzed first followed by less intense ones until reliable mass spectra could be obtained.
Matrix-assisted laser/desorption ionization-time of flight mass spectrometry (MALDI-TOF-MS)
Protein spots were excised from the gel using a pipette, and transferred into 1.5 mL Eppendorf tubes. In-gel trypsin (Promega, USA) digestion and sample preparation for MALDI-TOF analysis was carried out by the procedure of Shevchenko et al.15 After the overnight digestion, the samples were concentrated and desalted by ZipTip (Millipore) prior to applying on the sample plate. α-Cyano-4-hydroxycinnamic acid (Fluka, Switzerland) was recrystallized and used to prepare the matrix solution by dissolution at a concentration of 10 mg mL−1 in 70% acetonitrile/0.1% TFA. 0.5 μL peptide solution was deposited onto the MALDI target, rapidly followed by 0.5 μL of this matrix solution. The MALDI-TOF analysis was performed on a Voyager-DE STR MALDI-TOF mass spectrometer from Applied Biosystems (Foster City, CA) in the reflector mode. External mass calibration was achieved utilizing calibration mixture 2 of the Sequazyme peptide mass standard kit (Perseptive Biosystems). The proteins were identified by searching a bacterial subset in the NCBInr database using the Mascot program (www.matrixscience.com). The search parameters were set up as follows: enzyme was trypsin, the number of missed cleavage site was allowed up to 1, the variable modification was oxidation of methionine, the mass tolerance of precursor ions and fragments was 0.5 Da. The estimated molecular weight and pI of the candidate protein were in agreement with the assignment.
Results
Cultures of A. oremlandii, regardless of growth medium content, grew to maximum cell densities by 72 h. During this time, the yellow color of the medium that contained roxarsone disappeared, indicating its transformation.11
Proteomic analysis of cell lysates employing 2-D Gel Electrophoresis (2-DE) and MALDI-TOF Mass Spectrometry (MALDI-TOF MS)
In order to analyze the changes in protein profile affected by roxarsone, 2-DE was employed to compare the protein expressions of the cells grown on different substrates. In this case, cells grown on lactate only serve as a control for differential expression. Isoelectric focusing was conducted in the pH range 3 to 11, which provided sufficient resolution for subsequent SDS-PAGE separation in the second dimension. From the stained gels, samples were excised for tryptic digestion for mass spectrometric analysis by MALDI-TOF on the abundant proteins. This approach resulted in the definitive identification of 70 proteins that corresponded to predicted protein-encoding gene models in the annotated genome of A. oremlandii (Table 1). While several spots in the gel were clearly different in their intensity, quantitative image analysis was inconsistent and thus was not followed further. Protein assignments were made by MALDI-TOF analysis, searching a subset in the NCBI database using the Mascot program. For protein fractions from both cells grown on lactate and cells grown on lactate with roxarsone, three biological triplicates were used for 2-DE analyses and many proteins were identified multiple times from multiple gels. The identified proteins (with names as annotated), with their GI accession number, molecular weight (MW), and isoelectric point (pI) are listed in Table 1. Representative 2D gels (stained with colloidal Coomassie Blue) showing the presence of a large number of proteins are shown in Fig. 1. The number and relative intensity of the protein spots appear to be similar whether the cells were grown on lactate alone (Fig. 1A) or lactate and roxarsone (Fig. 1B). Nevertheless, several spots were more intense in the roxarsone grown cells, in particular aldehyde ferredoxin oxidoreductase (AOR) (Fig. 1 inset).
 |
| | Fig. 1 Representative 2D gels (12.5% acrylamide, 3–11 pH range) of protein fractions from cells of A. oremlandii grown on lactate only (A) and lactate with roxarsone (B). The protein spots that were excised, in-gel digested with trypsin, and analyzed by MALDI-TOF-MS are shown in (C). The numbers correspond to the list of proteins in Table 1. The inset is a higher magnification of the spots identified as AOR. | |
Table 1
Proteins identified from 2-D PAGE (first 12 are metalloproteins)
| Spota |
Accession Nob |
Locusc |
Protein named |
MWe |
pIf |
Coverageg |
|
Spot numbers corresponding to those shown in Fig. 1.
Accession number from the NCBI genome sequence database for the gene corresponding to the A. oremlandii.
Locus tag number of the protein.
The protein annotation.
The predicted molecular mass of the identified protein.
The predicted pI of the identified protein.
MS sequence coverage.
|
| 8 |
gi|158319289 |
Clos_0237 |
Pyruvate flavodoxin/ferredoxin oxidoreductase domain protein |
129350 |
5.39 |
49 |
| 9 |
gi|158321165 |
Clos_2140 |
Aldehyde ferredoxin oxidoreductase
|
78249 |
5.58 |
65 |
| 13 |
gi|158320131 |
Clos_1096 |
Molybdopterin oxidoreductase
|
96667 |
6.32 |
63 |
| 14 |
gi|158319915 |
Clos_0879 |
Aldehyde oxidase and xanthine dehydrogenasemolybdopterin binding |
86888 |
6.22 |
32 |
| 15 |
gi|158321168 |
Clos_2143 |
Aldehyde ferredoxin oxidoreductase
|
77646 |
6.1 |
61 |
| 25 |
gi|158320201 |
Clos_1166 |
Oligoendopeptidase F |
70655 |
5.72 |
40 |
| 39 |
gi|158320977 |
Clos_1950 |
Flavodoxin/nitric oxide synthase |
44692 |
5.3 |
70 |
| 65 |
gi|158321150 |
Clos_2125 |
2-oxoglutarate ferredoxin oxidoreductase beta subunit |
31697 |
5.88 |
75 |
| 67 |
gi|158320077 |
Clos_1041 |
Pyruvate ferredoxin/flavodoxin oxidoreductase |
21142 |
5.27 |
86 |
| 74 |
gi|158321353 |
Clos_2331 |
Rubrerythrin |
22901 |
5.63 |
81 |
| 80 |
gi|158321166 |
Clos_2141 |
4Fe-4S ferredoxiniron-sulfur binding domain protein |
25858 |
7.35 |
49 |
| 81 |
gi|158321169 |
Clos_2144 |
FeS Protein |
25577 |
8.29 |
56 |
| 87 |
gi|158319291 |
Clos_0239 |
Desulfoferrodoxin ferrous iron-binding region |
13771 |
5.87 |
95 |
| 1 |
gi|158321647 |
Clos_2627 |
S-layer domain protein |
101935 |
4.79 |
55 |
| 2 |
gi|158319535 |
Clos_0484 |
DNA-directed RNA polymerase, beta subunit |
139338 |
4.8 |
26 |
| 3 |
gi|158321644 |
Clos_2624 |
S-layer
protein
|
82536 |
4.9 |
63 |
| 4 |
gi|158320998 |
Clos_1971 |
Phenylalanyl-tRNA synthetase, beta subunit |
89397 |
5.11 |
52 |
| 5 |
gi|158319540 |
Clos_0489 |
Translation elongation factor G |
76607 |
5.07 |
81 |
| 6 |
gi|158320724 |
Clos_1695 |
Cobalamin B12-binding domain protein |
82413 |
5.18 |
44 |
| 7 |
gi|158320991 |
Clos_1964 |
S-layer domain protein |
86229 |
5.28 |
28 |
| 10 |
gi|158321286 |
Clos_2264 |
Ig-like, group 2 |
102488 |
5.84 |
53 |
| 12 |
gi|158321863 |
Clos_2845 |
Peptidoglycan-binding domain 1 protein |
79856 |
8.07 |
42 |
| 16 |
gi|158321646 |
Clos_2626 |
Hypothetical protein Clos_2626 |
73325 |
4.83 |
58 |
| 17 |
gi|158321468 |
Clos_2447 |
Chaperonin GroEL |
57624 |
4.76 |
63 |
| 19 |
gi|158319637 |
Clos_0586 |
Pyruvate kinase
|
62886 |
5.06 |
70 |
| 20 |
gi|158320738 |
Clos_1709 |
Aspartyl-tRNA synthetase
|
67435 |
5.16 |
59 |
| 21 |
gi|158321621 |
Clos_2601 |
S-layer domain protein |
69204 |
5.2 |
34 |
| 22 |
gi|158320145 |
Clos_1110 |
Arsenite-activated ATPase ArsA |
64704 |
5.24 |
64 |
| 23 |
gi|158319487 |
Clos_0436 |
Methylmalonyl-CoA mutase, large subunit |
62272 |
5.26 |
52 |
| 24 |
gi|158321392 |
Clos_2371 |
RNA-metabolising metallo-beta-lactamase |
62384 |
5.53 |
30 |
| 26 |
gi|158319518 |
Clos_0467 |
Glutamyl-tRNA synthetase
|
56814 |
5.23 |
52 |
| 27 |
gi|158319995 |
Clos_0959 |
Sarcosine reductase
|
55790 |
5.52 |
64 |
| 28 |
gi|158321152 |
Clos_2127 |
Formate–tetrahydrofolate ligase |
60122 |
5.76 |
50 |
| 29 |
gi|158319446 |
Clos_0395 |
Acetyl-CoA carboxylase, biotin carboxylase |
51256 |
5.88 |
72 |
| 30 |
gi|158319584 |
Clos_0533 |
Inosine-5′-monophosphate dehydrogenase |
52507 |
7.16 |
37 |
| 31 |
gi|158320253 |
Clos_1218 |
DEAD/DEAH box helicase domain protein |
59230 |
8.4 |
66 |
| 32 |
gi|158319889 |
Clos_0851 |
Aminotransferase class I and II |
48776 |
4.99 |
72 |
| 33 |
gi|158319527 |
Clos_0476 |
Translation elongation factor Tu |
44098 |
5.22 |
76 |
| 36 |
gi|158320729 |
Clos_1700 |
Glycine hydroxymethyltransferase
|
45439 |
5.9 |
46 |
| 37 |
gi|158320624 |
Clos_1592 |
Phosphopentomutase
|
42818 |
5.03 |
76 |
| 38 |
gi|158321514 |
Clos_2493 |
FAD-dependent pyridine nucleotide-disulfide oxidoreductase |
47479 |
5.3 |
63 |
| 40 |
gi|158321641 |
Clos_2621 |
Outer membrane protein-like protein |
45956 |
5.83 |
68 |
| 41 |
gi|158321480 |
Clos_2459 |
Glu/Leu/Phe/Val dehydrogenase |
45250 |
5.56 |
73 |
| 42 |
gi|158319685 |
Clos_0636 |
Acyl-CoA dehydrogenase domain protein |
41315 |
6.06 |
79 |
| 43 |
gi|158320699 |
Clos_1670 |
Cysteine desulfurase
|
43625 |
6.07 |
45 |
| 44 |
gi|158320484 |
Clos_1451 |
Fatty acid/phospholipid synthesis protein PlsX |
36404 |
6.07 |
86 |
| 45 |
gi|158319945 |
Clos_0909 |
Pyridoxal phosphate-dependent acyltransferase |
43367 |
6.23 |
71 |
| 46 |
gi|158320194 |
Clos_1159 |
FMN-dependent alpha-hydroxy acid dehydrogenase |
36349 |
6.96 |
81 |
| 47 |
gi|158319997 |
Clos_0961 |
Basic membrane lipoprotein |
38677 |
4.46 |
59 |
| 48 |
gi|158319379 |
Clos_0327 |
Hypothetical protein Clos_0327 |
44008 |
4.37 |
52 |
| 49 |
gi|158319078 |
Clos_0019 |
Lipoyltransferase and lipoate-protein ligase |
38307 |
5.28 |
62 |
| 51 |
gi|158319585 |
Clos_0534 |
GMP synthase, large subunit |
36058 |
5.36 |
80 |
| 52 |
gi|158319301 |
Clos_0249 |
Methylenetetrahydrofolate dehydrogenase (NADP(+)) |
31199 |
5.43 |
63 |
| 54 |
gi|158319458 |
Clos_0407 |
Branched-chain amino acid aminotransferase
|
37699 |
5.74 |
39 |
| 55 |
gi|158319760 |
Clos_0712 |
D-isomer specific 2-hydroxyacid dehydrogenase NAD-binding |
36170 |
5.71 |
51 |
| 56 |
gi|158321288 |
Clos_2266 |
Transketolase central region |
33448 |
5.94 |
83 |
| 58 |
gi|158320546 |
Clos_1514 |
Translation elongation factor
Ts
|
24318 |
5.2 |
67 |
| 60 |
gi|158319309 |
Clos_0257 |
Short-chain dehydrogenase/reductase SDR |
26077 |
5.27 |
43 |
| 61 |
gi|158319300 |
Clos_0248 |
Nitroreductase |
30984 |
5.46 |
87 |
| 66 |
gi|158319887 |
Clos_0849 |
Short-chain dehydrogenase/reductase SDR |
27513 |
5.64 |
60 |
| 68 |
gi|158321147 |
Clos_2122 |
CBS domain containing protein |
22284 |
5.6 |
52 |
| 69 |
gi|158321130 |
Clos_2105 |
HAD-superfamily subfamily IB hydrolase |
28373 |
6 |
68 |
| 70 |
gi|158319749 |
Clos_0701 |
Stress protein |
21929 |
6.08 |
72 |
| 73 |
gi|158319724 |
Clos_0675 |
Redoxin domain protein |
19047 |
5.11 |
88 |
| 75 |
gi|158320386 |
Clos_1352 |
ATP—cobalamin adenosyltransferase |
20342 |
5.64 |
81 |
| 76 |
gi|158319190 |
Clos_0134 |
Isochorismatase hydrolase |
20665 |
5.79 |
65 |
| 77 |
gi|158320393 |
Clos_1360 |
Propanediol utilization protein |
20972 |
5.75 |
49 |
| 78 |
gi|158319530 |
Clos_0479 |
NusG antitermination factor |
19838 |
6.36 |
61 |
| 83 |
gi|158320813 |
Clos_1784 |
NUDIX hydrolase |
17427 |
5.93 |
97 |
| 85 |
gi|158319578 |
Clos_0527 |
Ribosomal protein L13 |
16124 |
9.7 |
74 |
Discussion
The mass spectrometric analysis revealed the identity of 70 proteins. While the majority of the proteins detected have known function, four proteins (Clos_2624, Clos_2626, Clos_0327, Clos_2214) were annotated as hypothetical proteins in the A. oremlandiigenome (http://genome.ornl.gov/microbial/clos/). While the functions of these proteins are yet to be understood, they are nevertheless expressed under the growth conditions used in this study, and therefore are no longer hypothetical. In addition, the protein designated as molybdopterin oxidoreductase has now been confirmed to be respiratory arsenate reductase (Clos_1096, gi|158320131).16 Proteomic studies indicate that one of the major proteins is S-layer or surface layer protein, which is a common structural component for bacterial cells. Consistent with the cell growth this protein is prominently expressed both in lactate grown and roxarsone with lactate grown cells. Several proteins such as glycine dehydrogenase and Glu/Leu/Phe/Val dehydrogenase that are involved in the amino acidmetabolism were identified. Similarly, proteins involved in transcription and translation were also identified, as well as those (e.g., Inosine-5′-monophosphate dehydrogenase) involved in nucleotide biosynthesis. While many of these proteins are of interest, we focus here on those that may be involved in organoarsenical biotransformation.
Previous studies demonstrated that under the conditions the cells were grown, two major products were detected.11 Nearly 66% of the roxarsone was converted to 3-amino-4-hydroxy-benzenearsonic acid (3A4HBAA) through reduction of the nitro-group. The remaining roxarsone was converted to arsenate, which resulted from either direct ring cleavage or complete conversion of the aromatic ring into a C1 compound. We hypothesized the latter mechanism may be operating.11 At the same time lactate is consumed and acetate is produced.
In principle, roxarsone can accept reducing equivalents that are generated during fermentation (with ATP generated by substrate level phosphorylation of acetyl-CoA), or a terminal electron acceptor linked to oxidative phosphorylation. The genome of A. oremlandii contains genes that encode for proteins required for both the fermentation of lactate and glycolysis. Consistent with this, pyruvate kinase that is involved in the final step in glycolysis in the conversion of phosphoenolpyruvate to pyruvate, with concomitant phosphorylation of ADP to ATP, was identified by MALDI-TOF MS (Table 1). In the acrylate pathway, that generates acetate, enzymes such as lactate dehydrogenase, pyruvate-ferredoxin oxidoreductase, phosphotransacetylase, acetate kinase are involved. Many of these enzymes are found to be present in the genome, but of these, only pyruvate flavodoxin/ferredoxin oxidoreductase (Clos_0237, gi|158319289) has been detected in the roxarsone grown cells. Thus, acrylate pathway may be operative regardless whether roxarsone is present or not in the growth media.
The reduction of nitrophenols can proceed under aerobic as well as anaerobic conditions and can be carried out by a range of organisms17 either by oxidation or by reduction in the presence of an exogenous carbon source to aminoaromatics. The reduction of nitro groups on aromatic compounds by Clostridia is well known.18 For example, C. celerescence is capable of using hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) as a nitrogen source.19 Furthermore, the reduction of the nitro group has been shown to be dependent on the availability of reducing equivalents.20 Genomic analysis of A. oremlandii revealed the presence of two homologues of pentaerythritol tetranitrate reductase (NemA), several nitroreductases, carbon monoxide dehydrogenase, and hydrogenase, all of which have been implicated in the reduction of nitro groups on aromatic compounds. Thus, the reduction of the nitrogroup in roxarsone, in principle, can be carried out by any of these enzymes where the reducing equivalents could be generated from the fermentation of lactate. We have identified five nitroreductases in the genome of A. oremlandii. The five homologues differ in amino acid sequence, molecular mass, and pI and with varying operon structures. Indeed sequence alignment of the nitroreductases shown in Fig. 2 indicates very little homology. Of those, we have detected the largest one (Clos_0248, gi|158319300) indicating that at least this protein is expressed. Future functional assays will reveal whether this protein can reduce the nitro group in roxarsone. From the analysis of the gel images, it appears that this nitroreductase is present in both conditions, thus being expressed constitutively.
 |
| | Fig. 2 Sequence alignment by Clustal 2.0.11 of five homologues of nitroreductase. Identified homologue Clos_0248, gi|158319300, in bold red are the peptide fragments identified by MALDI-TOF (79% coverage). | |
We hypothesized that the release of inorganic arsenic from roxarsone follows complete degradation of the aromatic ring. Aerobic degradation of nitroaromatics that serve as a source of carbon and nitrogen are known to proceed through complete conversion to inorganic species. Often these reactions are carried out by monooxygenases or dioxygenases. For example, monooxygenase from Pseudomonas sp., has been demonstrated to convert 4-nitrophenol to hydroquinone, with the release of nitrite at the expense of two moles of NADPH per mole of 4-nitrophenol.21 The hydroquinone formed served as a substrate for ring fission forming γ-hydroxy muconic semialdehyde, which is further oxidized to maleyl acetic acid and then to β-ketoadipic acid.21 Alternatively the degradation can proceed viahydroxylation of the ring followed by ring fission to maleyl acetic acid and finally to β-ketoadipic acid.22 Both processes proceed aerobically and suggest an alternative pathway may be operative in the present case. Boll and others have proposed that the anaerobic degradation of the benzene ring proceeds via a benzyl CoA reductase pathway where the CoA activates the ring followed by reduction of the ring, which is subsequently degraded to CO2.23–26 Interestingly, aldehyde ferredoxin oxidoreductase (AOR), a pterin containing molybdoprotein, was found to be expressed at a higher level in cells grown in roxarsone (see Fig. 1, inset). The genome of A. oremlandii contains two homologues of AOR and both copies are found to be expressed at higher level, but to different extents, in roxarsone grown cells. AOR is a hydroxylase that belongs to the xanthine oxidase family of molybdenum enzymes that can hydroxylate an organic substrate. This enzyme is in the same family as benzoyl CoA reductase. Based on the 2-DE data it is provocative to hypothesize that AOR may be involved in the degradation of roxarsone. Whether roxarsone can function as a direct substrate to AOR or its degradation product serves as a substrate remains to be examined. The identification of the AOR is not limited to only one particular spot in the gel, rather peptide sequences obtained from the mass spectral data from several spots matches with the AOR. These spots do not differ in molecular mass but rather differ in their pI. Thus, we suggest that post translational modification of AOR may be taking place (Fig. 3). In addition, genomic data revealed the presence of two different homologues of AOR (Clos_2140, gi|158321165, and Clos_2143, gi|158321168) and both were detected by mass spectral analysis. From the 2-DE, it appears that one of them (Clos_2140, gi|158321165) is expressed more than the other. Thus, both enzymes are expressed under similar regulatory conditions. Unlike the AOR from thermophilic organisms such as Pyrococcus furiosus which harbors W-containing AOR,27AOR from A. oremlandii is associated with an iron sulfur cluster protein. Both copies of the AOR have this iron-sulfur clusterprotein and they (Clos_2141, gi|158321166, and Clos_2144, gi|158321169) have been detected by mass spectrometry. Thus, the AOR from A. oremlandii is compositionally different from that of the P. furiosus.
 |
| | Fig. 3 Separation of aldehyde ferredoxine oxidoreductase (1) and pyruvate flavodoxin/ferredoxin oxidoreductase (2) employing a pH range 4–7 strip. The beating pattern is indicative post-translational modifications. These two proteins correspond to spot numbers 9 and 8, respectively in Fig. 1. | |
Another important question is whether roxarsone induces the arsenic resistance and respiratory genes. The resistance (ars) and respiratory (arr) operons are part of a large gene cluster and are separated by molybdenum cofactor biosynthetic genes. Recently, we have described the respiratory arsenate reductase functions as a bidirectional enzyme in certain bacteria including A. oremlandii.16 We have identified ArrA, which along with a smaller subunit ArrB make the functional arsenate reductase, in both lactate and roxarsone grown cells. Therefore, we conclude that respiratory arsenate reductaseA. oremlandii is constitutively expressed.
Summary
While bacterial degradation of roxarsone has been previously reported,9,11,12 the present study constitutes the first example of a proteomic investigation aimed at understanding the molecular mechanism of the process. We have utilized 2D gel electrophoresis coupled with mass spectrometry for identifying candidate proteins that might be involved in the roxarsone biotransformation. To this end, we have identified aldehyde oxidoreductase, nitroreductase, respiratory arsenate reductase, and arsenite activated ATPase, among others. We have also identified proteins that are important for glycolysis and amino acidmetabolism. This investigation also confirmed the existence of four different proteins that were annotated as ‘hypothetical’. It further demonstrates the utility of proteomics in the elucidation of new and novel biodegradative pathways.
Acknowledgements
We thank Prof. Matthias Boll for stimulating discussions. PB also acknowledges numerous discussions with the students of his senior seminar class (2009).
References
- Poultry-Production and Value 2008 Summary. National Agricultural Statistics Service USDA Washington, DC 2009: http://usda.mannlib.cornell.edu/usda/nass/PoulProdVa//2000s/09/PoulProdVa-05-29-09.txt.
- Y. Arai, A. Lanzirotti, S. Sutton, J. A. Davis and D. L. Sparks, Arsenic Speciation and Reactivity in Poultry Litter, Environ. Sci. Technol., 2003, 37, 4083–90 CrossRef CAS.
- J. R. Garbarino, A. J. Bednar, D. W. Rutherford, R. S. Beyer and R. L. Wershaw, Environmental Fate of Roxarsone in Poultry Litter. I. Degradation of Roxarsone during Composting, Environ. Sci. Technol., 2003, 37, 1509–14 CrossRef CAS.
- D. W. Rutherford, A. J. Bednar, J. R. Garbarino, R. Needham, K. W. Staver and R. L. Wershaw, Environmental Fate of Roxarsone in Poultry Litter. Part II. Mobility of Arsenic in Soils Amended with Poultry Litter, Environ. Sci. Technol., 2003, 37, 1515–20 CrossRef CAS.
- B. L. Brown, A. D. Slaughter and M. E. Schreiber, Controls on roxarsone transport in agricultural watersheds, Appl. Geochem., 2004, 20, 123–33.
- D. J. Thomas, J. X. Li, S. B. Waters, W. B. Xing, B. M. Adair, Z. Drobna, V. Devesa and M. Styblo, Arsenic (+3 oxidation state) methyltransferase and the methylation of arsenicals, Exp. Biol. Med., 2007, 232, 3–13 Search PubMed.
- P. Basu, R. N. Ghosh, L. E. Grove, L. Klei and A. Barchowsky, Angiogenic potential of 3-nitro-4-hydroxy benzene arsonic acid (Roxarsone), Environ. Health Perspect., 2008, 116, 520–23 CAS.
- K. C. Makris, S. Quazi, P. Punamiya, D. Sarkar and R. Datta, Fate of arsenic in swine waste from concentrated animal feeding operations, J. Environ. Qual., 2008, 37, 1626–33 CrossRef CAS.
- I. Cortinas, J. A. Field, M. Kopplin, J. R. Garbarino, A. J. Gandolfi and R. Sierra-Alvarez, Anaerobic biotransformation of roxarsone and related N-substituted phenylarsonic acids, Environ. Sci. Technol., 2006, 40, 2951–57 CrossRef CAS.
- K. Silbergeld Ellen and K. Nachman, The environmental and public health risks associated with arsenical use in animal feeds, Ann. N. Y. Acad. Sci., 2008, 1140, 346–57 CrossRef CAS.
- J. F. Stolz, E. Perera, B. Kilonzo, B. Kail, B. Crable, E. Fisher, M. Ranganathan, L. Wormer and P. Basu, Biotransformation of 3-nitro-4-hydroxybenzene arsonic acid (roxarsone) and release of inorganic arsenic by Clostridium species, Environ. Sci. Technol., 2007, 41, 818–23 CrossRef CAS.
- E. Fisher, A. M. Dawson, G. Polshyna, J. Lisak, B. Crable and E. Perera et al, Transformation of inorganic and organic arsenic by Alkaliphilus oremlandii sp. nov. strain OhILAs, Ann. N. Y. Acad. Sci., 2008, 1125(Incredible Anarobes), 230–41 CAS.
- P. Basu, C. Sparacino, P. Chovanec and J. F. Stolz, Investigating the Protein Expression in Bacteria Grown Under Different Growth Conditions, Ed., P. Basu and M. E. Johnson, Lancaster, DEStech Publications, Inc., 2009 Search PubMed.
- V. Neuhoff, R. Stamm and H. Eibl, Clear background and highly sensitive protein staining with Coomassie Blue dyes in polyacrylamide gels: A systematic analysis, Electrophoresis, 1985, 6, 427–48 CAS.
- A. Shevchenko, H. Tomas, J. Havlis, J. V. Olsen and M. Mann, In-gel digestion for mass spectrometric characterization of proteins and proteomes, Nat. Protoc., 2006, 1, 2856–60 Search PubMed.
- C. Richey, P. Chovanec, S. E. Hoeft, R. S. Oremland, P. Basu and J. F. Stolz, Respiratory arsenate reductase as a bidirectional enzyme, Biochem. Biophys. Res. Commun., 2009, 382, 298–302 CrossRef CAS.
- C. M. Peres and S. N. Agathos, Biodegradation of nitro-aromatic pollutants: from pathways to remediation, Biotechnol. Annu. Rev., 2000, 6, 197–220 Search PubMed.
- A. Esteve-Nunez, A. Caballero and J. L. Ramos, Biological Degradation of 2,4,6-trinitrotoluene, Microbiol. Mol. Biol. Rev., 2001, 65, 335–52 CrossRef CAS.
- J.-S. Zhao, J. Spain and J. Hawari, Phylogenetic and metabolic diversity of hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX)-transforming bacteria in strictly anaerobic mixed cultures enriched on RDX as nitrogen source, FEMS Microbiol. Ecol., 2003, 46, 189–96 CrossRef CAS.
- N. R. Adrian, C. M. Arnett and R. F. Hickey, Stimulating the anaerobic biodegradation of explosives by the addition of hydrogen or electron donors that produce hydrogen, Water Res., 2003, 37, 3499–507 CrossRef CAS.
- J. C. Spain and D. T. Gibson, Pathway for biodegradation of p-nitrophenol in a Moraxella sp, App. Env. Microbiol., 1991, 57, 812–19 CAS.
- R. K. Jain, J. W. Dreisbach and J. C. Spain, Biodegradation of p-nitrophenol via 1,2,3-benzenetriol by an Arthrobacter sp., Applied Environmental Microbiology, 1994, 59, 340–43 Search PubMed.
- M. Boll, Dearomatizing benzene ring reductases, J. Mol. Microbiol. Biotechnol., 2005, 10, 132–42 CrossRef CAS.
- M. Boll, Key enzymes in the anaerobic aromatic metabolism catalyzing Birch-like reductions, Biochim. Biophys. Acta, Bioenerg., 2005, 1707, 34–50 CrossRef CAS.
- M. Boll and G. Fuchs, Unusual reactions involved in anaerobic metabolism of phenolic compounds, Biol. Chem., 2005, 386, 989–97 CrossRef CAS.
- C. S. Harwood, G. Burchhardt, H. Herrmann and G. Fuchs, Anaerobic metabolism of aromatic compounds via the benzoyl-CoA pathway, FEMS Microbiol. Rev., 1999, 22, 439–58.
- M. K. Johnson and D. C. Rees, Adams MWW. Tungstoenzymes, Chem. Rev., 1996, 96, 2817–39 CrossRef CAS.
|
| This journal is © The Royal Society of Chemistry 2010 |
Click here to see how this site uses Cookies. View our privacy policy here.